1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 End User Analysis 3.7 Emerging Markets 3.8 Futuristic Market Scenario 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Prostate Cancer Market, By Type 5.1 Introduction 5.2 Hormone Sensitive 5.3 Hormone Refractory 6 Global Prostate Cancer Market, By Therapy 6.1 Introduction 6.2 Focal Therapies 6.3 Biologic Therapy 6.4 Cryosurgery 6.5 Immunotherapy 6.5.1 Vaccines 6.6 Therapeutic Vaccines 6.6.1 Provenge (Sipuleucel-T) 6.7 Radiation Therapy 6.7.1 External Beam 6.7.1.1 Stereotactic Body 6.7.1.2 Proton Beam 6.7.1.3 Intensity Modulated 6.7.1.4 3D Conformal 6.7.2 Brachytherapy 6.7.2.1 Temporary 6.7.2.2 Permanent 6.8 Chemotherapy 6.8.1 Vinorelbine 6.8.2 Vinblastine 6.8.3 Taxotere (Docetaxel) 6.8.4 Taxanes 6.8.5 Jevtana (Cabazitaxel) 6.8.6 Etoposide 6.8.7 Cytotoxic Drugs 6.8.8 Carboplatin 6.8.9 Antimetabolites 6.8.10 Anthracyclines 6.8.11 Alkylating Agents 6.9 Surgery 6.9.1 Trans Urethral Resection (TUR) 6.9.2 Radical Prostatectomy 6.9.3 Orchidectomy 6.10 Targeted Therapy 6.10.1 Tyrosine Kinase Inhibitors 6.10.2 Signal Transduction Inhibitor 6.10.3 Monoclonal Antibodies 6.10.4 Apoptosis Inducing Drugs 6.10.5 Angiogenesis Inhibitor 6.11 Bone Metastasis 6.11.1 Zometa (Zoledronic Acid) 6.11.2 Xofigo (Radium 223 Dichloride) 6.11.3 Xgeva (Denosumab) 6.11.4 Alpharadin 6.12 Hormonal Therapy 6.12.1 Aromatase Inhibitors 6.12.2 Estrogen-Receptor Modulators (Serms) 6.12.3 Luteinizing Hormone–Releasing Hormone (LHRH) Analogs 6.12.3.1 Lupron 6.12.3.2 Zoladex 6.12.3.3 Decapeptyl 6.12.3.4 Eligard 6.12.3.5 Vantas 6.12.3.6 Leuplin 6.12.3.7 Trelstar (Triptorelin Pamoate) 6.12.3.8 Firmagon (Degarelix) 6.12.3.9 Casodex (Bicalutamide) 6.12.4 Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists 6.12.4.1 Zytiga 6.12.4.2 Gonax 6.12.4.3 Xtandi (Enzalutamide) 6.12.5 Anti–Androgens 6.12.5.1 Casodex 6.12.5.2 Xtandi or MDV3100 6.12.5.3 Xtandi US or MDV3100 6.12.6 Other Hormonal Therapies 7 Global Prostate Cancer Market, By Diagnostic Technique 7.1 Introduction 7.2 Prostate Specific Antigen Test (PSA) 7.3 Digital Rectal Exam (DRE) 8 Global Prostate Cancer Market, By End User 8.1 Introduction 8.2 Ambulatory Surgical Centers 8.3 Hospitals 8.4 Pharmacies 8.5 Specialty Clinics 8.6 Other End Users 9 Global Prostate Cancer Market, By Geography 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.2.3 Mexico 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 Italy 9.3.4 France 9.3.5 Spain 9.3.6 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 New Zealand 9.4.6 South Korea 9.4.7 Rest of Asia Pacific 9.5 South America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Chile 9.5.4 Rest of South America 9.6 Middle East & Africa 9.6.1 Saudi Arabia 9.6.2 UAE 9.6.3 Qatar 9.6.4 South Africa 9.6.5 Rest of Middle East & Africa 10 Key Developments 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Astellas, Inc. 11.2 AstraZeneca plc 11.3 Bristol Myers Squibb (BMS) 11.4 Johnson & Johnson 11.5 NOVARTIS 11.6 Sanofi S.A 11.7 TOLMAR Inc. 11.8 Tokai Pharmaceuticals 11.9 Progenics Pharmaceuticals Inc. 11.10 OncoGenex Pharmaceuticals Inc. 11.11 OncBioMune Pharmaceuticals Inc. 11.12 Endo Pharmaceuticals 11.13 Bayer Pharma AG List of Tables 1 Global Prostate Cancer Market Outlook, By Region (2016-2026) (US $MN) 2 Global Prostate Cancer Market Outlook, By Type (2016-2026) (US $MN) 3 Global Prostate Cancer Market Outlook, By Hormone Sensitive (2016-2026) (US $MN) 4 Global Prostate Cancer Market Outlook, By Hormone Refractory (2016-2026) (US $MN) 5 Global Prostate Cancer Market Outlook, By Therapy (2016-2026) (US $MN) 6 Global Prostate Cancer Market Outlook, By Focal Therapies (2016-2026) (US $MN) 7 Global Prostate Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 8 Global Prostate Cancer Market Outlook, By Cryosurgery (2016-2026) (US $MN) 9 Global Prostate Cancer Market Outlook, By Immunotherapy (2016-2026) (US $MN) 10 Global Prostate Cancer Market Outlook, By Vaccines (2016-2026) (US $MN) 11 Global Prostate Cancer Market Outlook, By Therapeutic Vaccines (2016-2026) (US $MN) 12 Global Prostate Cancer Market Outlook, By Provenge (Sipuleucel-T) (2016-2026) (US $MN) 13 Global Prostate Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 14 Global Prostate Cancer Market Outlook, By External Beam (2016-2026) (US $MN) 15 Global Prostate Cancer Market Outlook, By Brachytherapy (2016-2026) (US $MN) 16 Global Prostate Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 17 Global Prostate Cancer Market Outlook, By Vinorelbine (2016-2026) (US $MN) 18 Global Prostate Cancer Market Outlook, By Vinblastine (2016-2026) (US $MN) 19 Global Prostate Cancer Market Outlook, By Taxotere (Docetaxel) (2016-2026) (US $MN) 20 Global Prostate Cancer Market Outlook, By Taxanes (2016-2026) (US $MN) 21 Global Prostate Cancer Market Outlook, By Jevtana (Cabazitaxel) (2016-2026) (US $MN) 22 Global Prostate Cancer Market Outlook, By Etoposide (2016-2026) (US $MN) 23 Global Prostate Cancer Market Outlook, By Cytotoxic Drugs (2016-2026) (US $MN) 24 Global Prostate Cancer Market Outlook, By Carboplatin (2016-2026) (US $MN) 25 Global Prostate Cancer Market Outlook, By Antimetabolites (2016-2026) (US $MN) 26 Global Prostate Cancer Market Outlook, By Anthracyclines (2016-2026) (US $MN) 27 Global Prostate Cancer Market Outlook, By Alkylating Agents (2016-2026) (US $MN) 28 Global Prostate Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 29 Global Prostate Cancer Market Outlook, By Trans Urethral Resection (TUR) (2016-2026) (US $MN) 30 Global Prostate Cancer Market Outlook, By Radical Prostatectomy (2016-2026) (US $MN) 31 Global Prostate Cancer Market Outlook, By Orchidectomy (2016-2026) (US $MN) 32 Global Prostate Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 33 Global Prostate Cancer Market Outlook, By Tyrosine Kinase Inhibitors (2016-2026) (US $MN) 34 Global Prostate Cancer Market Outlook, By Signal Transduction Inhibitor (2016-2026) (US $MN) 35 Global Prostate Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) (US $MN) 36 Global Prostate Cancer Market Outlook, By Apoptosis Inducing Drugs (2016-2026) (US $MN) 37 Global Prostate Cancer Market Outlook, By Angiogenesis Inhibitor (2016-2026) (US $MN) 38 Global Prostate Cancer Market Outlook, By Bone Metastasis (2016-2026) (US $MN) 39 Global Prostate Cancer Market Outlook, By Zometa (Zoledronic Acid) (2016-2026) (US $MN) 40 Global Prostate Cancer Market Outlook, By Xofigo (Radium 223 Dichloride) (2016-2026) (US $MN) 41 Global Prostate Cancer Market Outlook, By Xgeva (Denosumab) (2016-2026) (US $MN) 42 Global Prostate Cancer Market Outlook, By Alpharadin (2016-2026) (US $MN) 43 Global Prostate Cancer Market Outlook, By Hormonal Therapy (2016-2026) (US $MN) 44 Global Prostate Cancer Market Outlook, By Aromatase Inhibitors (2016-2026) (US $MN) 45 Global Prostate Cancer Market Outlook, By Estrogen-Receptor Modulators (Serms) (2016-2026) (US $MN) 46 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Analogs (2016-2026) (US $MN) 47 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists (2016-2026) (US $MN) 48 Global Prostate Cancer Market Outlook, By Anti–Androgens (2016-2026) (US $MN) 49 Global Prostate Cancer Market Outlook, By Other Hormonal Therapies (2016-2026) (US $MN) 50 Global Prostate Cancer Market Outlook, By Diagnostic Technique (2016-2026) (US $MN) 51 Global Prostate Cancer Market Outlook, By Prostate Specific Antigen Test (PSA) (2016-2026) (US $MN) 52 Global Prostate Cancer Market Outlook, By Digital Rectal Exam (DRE) (2016-2026) (US $MN) 53 Global Prostate Cancer Market Outlook, By End User (2016-2026) (US $MN) 54 Global Prostate Cancer Market Outlook, By Ambulatory Surgical Centers (2016-2026) (US $MN) 55 Global Prostate Cancer Market Outlook, By Hospitals (2016-2026) (US $MN) 56 Global Prostate Cancer Market Outlook, By Pharmacies (2016-2026) (US $MN) 57 Global Prostate Cancer Market Outlook, By Specialty Clinics (2016-2026) (US $MN) 58 Global Prostate Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.